DE602005021078D1 - Interferon-beta zur antiviralen therapie für atemwegserkrankungen - Google Patents
Interferon-beta zur antiviralen therapie für atemwegserkrankungenInfo
- Publication number
- DE602005021078D1 DE602005021078D1 DE602005021078T DE602005021078T DE602005021078D1 DE 602005021078 D1 DE602005021078 D1 DE 602005021078D1 DE 602005021078 T DE602005021078 T DE 602005021078T DE 602005021078 T DE602005021078 T DE 602005021078T DE 602005021078 D1 DE602005021078 D1 DE 602005021078D1
- Authority
- DE
- Germany
- Prior art keywords
- interferon beta
- agent
- respiratory diseases
- antiviral therapy
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 102000003996 Interferon-beta Human genes 0.000 title abstract 3
- 108090000467 Interferon-beta Proteins 0.000 title abstract 3
- 229960001388 interferon-beta Drugs 0.000 title abstract 3
- 230000000840 anti-viral effect Effects 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 230000000241 respiratory effect Effects 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
- 239000003795 chemical substances by application Substances 0.000 abstract 4
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 abstract 1
- 241000709661 Enterovirus Species 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 230000005713 exacerbation Effects 0.000 abstract 1
- 210000004072 lung Anatomy 0.000 abstract 1
- 102000040430 polynucleotide Human genes 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 239000002157 polynucleotide Substances 0.000 abstract 1
- 208000023504 respiratory system disease Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/215—IFN-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
- A61M16/10—Preparation of respiratory gases or vapours
- A61M16/14—Preparation of respiratory gases or vapours by mixing different fluids, one of them being in a liquid phase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Anesthesiology (AREA)
- Emergency Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0405634.7A GB0405634D0 (en) | 2004-03-12 | 2004-03-12 | Anti-virus therapy for respiratory diseases |
| PCT/GB2005/050031 WO2005087253A2 (en) | 2004-03-12 | 2005-03-07 | Interferon-beta for anti-virus therapy for respiratory diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE602005021078D1 true DE602005021078D1 (de) | 2010-06-17 |
Family
ID=32117582
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE602005021078T Active DE602005021078D1 (de) | 2004-03-12 | 2005-03-07 | Interferon-beta zur antiviralen therapie für atemwegserkrankungen |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US7569216B2 (de) |
| EP (2) | EP2206512A3 (de) |
| JP (2) | JP4807526B2 (de) |
| AT (1) | ATE466591T1 (de) |
| CA (2) | CA2558212C (de) |
| DE (1) | DE602005021078D1 (de) |
| DK (1) | DK1734987T3 (de) |
| ES (1) | ES2343732T3 (de) |
| GB (1) | GB0405634D0 (de) |
| PL (1) | PL1734987T3 (de) |
| PT (1) | PT1734987E (de) |
| WO (1) | WO2005087253A2 (de) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0405634D0 (en) | 2004-03-12 | 2004-04-21 | Univ Southampton | Anti-virus therapy for respiratory diseases |
| US8318423B2 (en) * | 2004-07-06 | 2012-11-27 | Focus Diagnostics, Inc. | Methods and compositions for detecting rhinoviruses |
| JP5172679B2 (ja) * | 2005-09-09 | 2013-03-27 | インペリアル イノベーションズ リミテッド | 呼吸器疾患の治療のためのインターフェロン−λ療法 |
| KR20130110225A (ko) * | 2005-09-20 | 2013-10-08 | 뉴욕 유니버시티 | 인터페론을 사용하여 폐질환을 치료하는 방법 |
| DE102006022877B4 (de) * | 2006-05-15 | 2009-01-29 | Sartorius Stedim Biotech Gmbh | Verfahren zur Bestimmung der Viabilität von Zellen in Zellkulturen |
| US7871603B2 (en) | 2007-05-18 | 2011-01-18 | Synairgen Research Limited | Interferon-beta and/or lambda for use in treating rhinovirus infection in the elderly |
| GB0713402D0 (en) * | 2007-07-11 | 2007-08-22 | Cardiff & Vale Nhs Trust | A method of diagnosing a condition using a neural network |
| JP2011506396A (ja) * | 2007-12-13 | 2011-03-03 | グラクソ グループ リミテッド | 肺送達用組成物 |
| US20110236349A1 (en) * | 2008-12-19 | 2011-09-29 | Koff Jonathan L | Use of Epidermal Growth Factor Inhibitors in the Treatment of Viral Infection |
| EP2506759A4 (de) | 2009-12-02 | 2015-05-20 | Neetour Medical Ltd | Auf hämodynamik basierende überwachung und bewertung einer atmungserkrankung |
| HRP20161158T1 (hr) * | 2010-03-12 | 2016-11-18 | Synairgen Research Limited | Interferon beta za liječenje bolesti donjeg dišnog sustava izazvane gripom |
| JP2013537892A (ja) | 2010-09-22 | 2013-10-07 | ザ ユニバーシティー オブ メルボルン | 新規な免疫賦活法 |
| EP3954714A1 (de) | 2014-01-08 | 2022-02-16 | Prosit Sole Biotechnology (Beijing) Co. Ltd | Fusionspolypeptide und verfahren zur verwendung |
| EP3658118B1 (de) | 2017-07-24 | 2025-03-19 | Novavax, Inc. | Verfahren und zusammensetzungen zur behandlung von atemwegserkrankungen |
| JP7439367B2 (ja) | 2017-12-21 | 2024-02-28 | アクセリア オンコロジー ピーティーワイ リミテッド | 最適化化合物 |
| EP3923975A4 (de) * | 2019-02-13 | 2023-04-19 | University of Florida Research Foundation, Inc. | Targeting einer lungenresidenten tnfr2 + cdc2 (r2d2)-subpopulation zur behandlung von asthma |
| EP3990428A4 (de) | 2019-06-26 | 2023-07-19 | ENA Respiratory Pty Ltd | Neuartige moleküle |
| US20230338475A1 (en) | 2020-07-20 | 2023-10-26 | Synairgen Research Limited | USE OF INHALED INTERFERON-BETA TO IMPROVE OUTCOME IN SARS-CoV-2 INFECTED PATIENTS |
| GB202014114D0 (en) | 2020-09-08 | 2020-10-21 | Synairgen Res Ltd | Use of inhaled interferon-beta to treat virus-induced exacerbations in copd patients undergoing treatment with a systemic corticosteroid |
| AU2021375281A1 (en) * | 2020-11-04 | 2023-06-01 | Ethris Gmbh | Use of ifn-lambda mrna for treating viral infections |
| AU2022207315A1 (en) * | 2021-01-13 | 2023-08-03 | Abion Inc. | Prophylactic administration method against respiratory virus, comprising administering interferon-beta to potential respiratory virus-infected subject |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6596260B1 (en) * | 1993-08-27 | 2003-07-22 | Novartis Corporation | Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol |
| MX9605717A (es) * | 1994-05-18 | 1998-05-31 | Inhale Therapeutic Syst | Metodos y composiciones para la formulacion de polvo seco de interferones. |
| US6030609A (en) * | 1995-05-19 | 2000-02-29 | Case Western Reserve University | Method and composition for treating paramyxovirus |
| US20010031253A1 (en) * | 1996-07-24 | 2001-10-18 | Gruenberg Micheal L. | Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease |
| AU780270B2 (en) * | 2000-02-23 | 2005-03-10 | Association Francaise Contre Les Myopathies | Treatment of immune diseases |
| GB2362884A (en) | 2000-05-30 | 2001-12-05 | Isis Innovation | Extended duration of airway gene therapy |
| AU2002212107A1 (en) | 2000-11-02 | 2002-05-15 | Maxygen Aps | New multimeric interferon beta polypeptides |
| WO2002072019A2 (en) * | 2001-03-13 | 2002-09-19 | Vical Incorporated | Interferon-beta polynucleotide therapy for autoimmune and inflammatory diseases |
| AU2003215136A1 (en) | 2002-02-08 | 2003-09-02 | University Of Medicine And Dentistry Of New Jersey | Ifn-a/b-independent mechanism of antiviral protection |
| US20040037809A1 (en) * | 2002-06-28 | 2004-02-26 | Nastech Pharmaceutical Company Inc. | Compositions and methods for enhanced mucosal delivery of interferon beta |
| JP2006509041A (ja) | 2002-10-23 | 2006-03-16 | ザイモジェネティクス，インコーポレイティド | Ｉｌ−２８およびｉｌ−２９を用いるウイルス感染を治療するための方法 |
| US7157559B2 (en) | 2003-08-07 | 2007-01-02 | Zymogenetics, Inc. | Homogeneous preparations of IL-28 and IL-29 |
| GB0405634D0 (en) | 2004-03-12 | 2004-04-21 | Univ Southampton | Anti-virus therapy for respiratory diseases |
| WO2005097165A2 (en) | 2004-04-02 | 2005-10-20 | Zymogenetics, Inc. | Il-28 and il-29 cysteine mutants for treating viral infection |
-
2004
- 2004-03-12 GB GBGB0405634.7A patent/GB0405634D0/en not_active Ceased
-
2005
- 2005-03-07 EP EP10161661A patent/EP2206512A3/de not_active Withdrawn
- 2005-03-07 JP JP2007502414A patent/JP4807526B2/ja not_active Expired - Fee Related
- 2005-03-07 EP EP05708482A patent/EP1734987B1/de not_active Expired - Lifetime
- 2005-03-07 DE DE602005021078T patent/DE602005021078D1/de active Active
- 2005-03-07 CA CA2558212A patent/CA2558212C/en not_active Expired - Lifetime
- 2005-03-07 CA CA2787978A patent/CA2787978A1/en not_active Abandoned
- 2005-03-07 PL PL05708482T patent/PL1734987T3/pl unknown
- 2005-03-07 PT PT05708482T patent/PT1734987E/pt unknown
- 2005-03-07 WO PCT/GB2005/050031 patent/WO2005087253A2/en not_active Application Discontinuation
- 2005-03-07 DK DK05708482.4T patent/DK1734987T3/da active
- 2005-03-07 AT AT05708482T patent/ATE466591T1/de active
- 2005-03-07 ES ES05708482T patent/ES2343732T3/es not_active Expired - Lifetime
-
2006
- 2006-09-08 US US11/517,763 patent/US7569216B2/en not_active Expired - Lifetime
-
2009
- 2009-06-18 US US12/487,563 patent/US8273342B2/en not_active Expired - Fee Related
-
2011
- 2011-04-20 JP JP2011093677A patent/JP2011144201A/ja active Pending
-
2012
- 2012-08-16 US US13/587,752 patent/US9089535B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US20070134763A1 (en) | 2007-06-14 |
| HK1097181A1 (en) | 2007-06-22 |
| US7569216B2 (en) | 2009-08-04 |
| GB0405634D0 (en) | 2004-04-21 |
| EP1734987B1 (de) | 2010-05-05 |
| WO2005087253A2 (en) | 2005-09-22 |
| CA2558212C (en) | 2012-11-27 |
| ATE466591T1 (de) | 2010-05-15 |
| US20090257980A1 (en) | 2009-10-15 |
| EP1734987A2 (de) | 2006-12-27 |
| WO2005087253A3 (en) | 2005-11-24 |
| DK1734987T3 (da) | 2010-08-30 |
| EP2206512A3 (de) | 2013-01-09 |
| EP2206512A2 (de) | 2010-07-14 |
| CA2787978A1 (en) | 2005-09-22 |
| ES2343732T3 (es) | 2010-08-09 |
| JP2007528890A (ja) | 2007-10-18 |
| US8273342B2 (en) | 2012-09-25 |
| JP2011144201A (ja) | 2011-07-28 |
| PT1734987E (pt) | 2010-07-06 |
| CA2558212A1 (en) | 2005-09-22 |
| JP4807526B2 (ja) | 2011-11-02 |
| PL1734987T3 (pl) | 2010-10-29 |
| US9089535B2 (en) | 2015-07-28 |
| US20130209399A1 (en) | 2013-08-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE466591T1 (de) | Interferon-beta zur antiviralen therapie für atemwegserkrankungen | |
| CY1108326T1 (el) | ΝΕΟΣ ΣΥΝΔΥΑΣΜΟΣ ΑΝΤΙΧΟΛΙΝΕΡΓΙΚΩΝ ΚΑΙ β ΜΙΜΗΤΙΚΩΝ ΓΙΑ ΤΗΝ ΘΕΡΑΠΕΙΑ ΑΝΑΠΝΕΥΣΤΙΚΩΝ ΑΣΘΕΝΕΙΩΝ | |
| ATE421325T1 (de) | Kombination von methylxanthinverbindungen und steroiden zur behandlung chronischer atemwegserkrankungen | |
| RS20050484A (en) | Powdered medicament for inhalation comprising a tiotropium salt and salmeterol xinafoate | |
| UY26959A1 (es) | Nuevos polvos para inhalación que contienen tiotropio | |
| SG171607A1 (en) | Respiratory devices and methods of use | |
| DE602005026007D1 (de) | Opioide zur behandlung von chronisch-obstruktiver lungenerkrankung (copd) | |
| JP2011144201A5 (de) | ||
| WO2007109118A3 (en) | RECOMBINANT HUMAN CC 10 (rhCC10) FOR TREATMENT OF RESPIRATORY DISORDERS | |
| MY146628A (en) | Novel crystalline anhydride with anticholinergic effect | |
| CY1108420T1 (el) | Προτοτυπο τιοτροπιουχο κονιωδες σκευασμα για εισπνοη | |
| MXPA03011702A (es) | Composicion que comprende un inhibidor de fosodiesterasa 4 y un antagonista de receptor h1 y el uso de los mismos para la elaboracion de un medicamento para el tratamiento de enfermedades respiratorias. | |
| NO20073909L (no) | Forstover-formulering | |
| RS20060292A (en) | Method for producing tiotropium salts, tiotropium salts and pharmaceutical formulations, containing the same | |
| EA200701077A1 (ru) | Применение конъюгатов липидов при лечении заболеваний | |
| BR0307235A (pt) | Composição para inalação | |
| MXPA04002401A (es) | Nuevos medicamentos para inhalacion. | |
| Sperry et al. | C52 CRITICAL CARE CASE REPORTS: RESPIRATORY FAILURE/MECHANICAL VENTILATION: Recurrent Pneumonia Caused By Diffuse Laryngotracheal Stenosis As A Consequence Of Prior Prolonged Intubation In A Patient With Systemic Lupus Erythematosus | |
| Szabari et al. | Effects Of Mechanical Stresses On The Structure-Function Relations During The Progression Of Elastase-Induced Emphysema | |
| GB2430622A (en) | Combination of methylxanthine compounds and steroids to treat chronic respiratory diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |